The chart above plots the price of PTGX over the range selected — one day to the full history — drawn by TradingView from their own data. Our own licensed end-of-day series holds 40 sessions over that window: $100.92 on 20 May 2026 through $141 on 17 July 2026.
Market cap$9.1B
P/E (TTM)120.5
52-week range$51 – $141
Avg volume152.2K
Finazon · prior-day close · valuation computed from SEC EDGAR filings · as of Aug 18, 2026
PTGX insider trades
SEC Form 4
PTGX has no Form 4 filing in the last 90 days, so there is no summary for that window. The most recent filings we hold are below, the newest dated 21 November 2025.
DateInsiderTypeSharesValue
17 Nov 2025MOLINA ARTURO MDChief Medical OfficerSell2,712$230K
10 Oct 2025Waddill William D.Sell12,000$979K
22 Sep 2025Waddill William D.Sell4,000$257K
27 Aug 2025Waddill William D.Sell4,000$237K
25 Jul 2025PATEL DINESH V PH DPresident and CEOSell10,415$571K
23 Jul 2025PATEL DINESH V PH DPresident and CEOSell17,520$960K
22 Jul 2025PATEL DINESH V PH DPresident and CEOSell22,065$1.21M
21 Jul 2025PATEL DINESH V PH DPresident and CEOSell12,859$705K
Compensation mechanics
Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.
DateInsiderTypeSharesValue
21 Nov 2025PATEL DINESH V PH DPresident and CEOGift440
10 Oct 2025Waddill William D.Option exercise12,000$84K
16 Sep 2025PATEL DINESH V PH DPresident and CEOGift620
21 Jul 2025PATEL DINESH V PH DPresident and CEOAward25,000
16 Jul 2025PATEL DINESH V PH DPresident and CEOGift5,000
PTGX reported financials
SEC EDGAR XBRL
PTGX reported revenue of $46.0M for the fiscal year ended 31 Dec 2025. Net income over the same period was −$130.1M.
FigureReportedPeriod
Revenue
$46.0M
31 Dec 2025 fiscal year
Net income
−$130.1M
31 Dec 2025 fiscal year
Diluted EPS
−$2.05
31 Dec 2025 fiscal year
Total assets
$885.5M
30 Jun 2026 at period end
Total equity
$841.5M
30 Jun 2026 at period end
Source: SEC EDGAR XBRL company facts · latest period ended 30 Jun 2026
PTGX earnings
SEC EDGAR
DatePeriodEPSRevenue
30 Jun 2026Q2 2026$2.29—
31 Mar 2026Q1 2026$0.05—
31 Dec 2025FY 2025$-2.05—
30 Sep 2025Q3 2025$-0.62—
30 Jun 2025Q2 2025$-0.55—
31 Mar 2025Q1 2025$-0.19—
31 Dec 2024FY 2024$4.23—
30 Sep 2024Q3 2024$-0.54—
Next report no date announced in SEC filings yet
Reported figures & scheduled dates · SEC EDGAR filings
PTGX institutional holders
SEC Form 13F
6 of the 45 institutional funds we track reported a PTGX position for the quarter ended 30 Jun 2026 — a combined $63.1M; the latest of those filings landed 14 Aug 2026.